Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00970749 · ClinicalTrials.gov registry record
Antigen-Specific Cell Mediated Immune Response to Chlamydia Trachomatis
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 55
- Enrollment target
NCT00970749 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 55 participants.
The verdict
NCT00970749 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 55 participants
- Enrollment target
Study Summary
This is an exploratory study in which the investigators will develop a way to identify the cell responses most strongly associated with protection against chlamydia infection. This study is not driven by a hypothesis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2009-12 |
| Est. Completion | 2010-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00970749
The ClinicalTrials.gov registry entry for NCT00970749 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00970749 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00970749 about?
NCT00970749 is a clinical study titled "Antigen-Specific Cell Mediated Immune Response to Chlamydia Trachomatis". This is an exploratory study in which the investigators will develop a way to identify the cell responses most strongly associated with protection against chlamydia infection. This study is not driven by a hypothesis.
What is the current status of trial NCT00970749?
This trial is currently completed. The enrollment target is 55 participants. The study started on 2009-12. Estimated completion is 2010-06.
Who is sponsoring clinical trial NCT00970749?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.